Abstract
The contribution of cardiac disease, especially ischemic heart disease, to the risk of noncardiac surgery cannot be overstated. The literature pertaining to the evaluation and treatment of patients with cardiac conditions in the perioperative setting is by far the most investigated and developed domain of perioperative medicine. This association has spawned consensus statements that guide best medical practice “as reported by Fleisher et al. (J Am Coll Cardiol 50:e159–242, 2007) and is a major consideration in professional societies devoted to this clinical domain.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol. 2007;50:e159–242.
Han C, Robinson DW, Hackett MV, et al. Cardiovascular disease and risk factors in patients with rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis. J Rheumatol. 2006;33(11):2167–72.
Avina-Zubieta JA, Choi HK, Sadatsafavi M, et al. Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies. Arthritis Rheum. 2008;59(12):1690–7.
Chung CP, Oeser A, Avalos I, et al. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther. 2006;8(6):1–7.
Manzi S, Wasko MC. Inflammation-mediated rheumatic diseases and atherosclerosis. Ann Rheum Dis. 2000;59:321–5.
Fischer LM, Schlienger RG, Matter C, et al. Effect of rheumatoid arthritis or systemic lupus erythematosus on the risk of first-time acute myocardial infarction. Am J Cardiol. 2004;93:198–200.
Hak AE, Karlson EW, Feskanich D, et al. Systemic lupus erythematosus and the risk of cardiovascular disease: results for the Nurses’ health study. Arthritis Rheum. 2009;61(10):1396–402.
Roman MJ, Crow MK, Lockshin MD, et al. Rate and determinants of progression of atherosclerosis in Âsystemic lupus erythematosus. Arthritis Rheum. 2007;56(10):3412–9.
Roman MJ, Shanker BA, Davis A, et al. Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus. N Eng J Med. 2003;349:2399–406.
Asanuma Y, Oeser A, Shintani AK, et al. Premature coronary-artery atherosclerosis in systemic lupus erythematosus. N Eng J Med. 2003;349:2407–15.
Manzi S, Selzer F, Sutton-Tyrrell K, et al. Prevalence and risk factors of carotid plaque in women with systemic lupus erythematosus. Arthritis Rheum. 1999;42(1):51–60.
Manzi S, Meilahn EH, Rairie JE, et al. Age-specific incidence rates of myocardial infarction and angina in woman with systemic lupus erythematosus: comparison with the Framingham study. Am J Epidemiol. 1997;145(5):408–15.
Ross R. Atherosclerosis-an inflammatory disease. N Eng J Med. 1999;340(2):115–26.
Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002;105:1135–43.
Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Eng J Med. 2005;352:1685–95.
Urban MK, Jules-Elysee KM, Beckman JB, et al. Pulmonary injury in patients undergoing complex spine surgery. Spine J. 2005;5:269–76.
Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study. Arthritis Rheum. 2005;52:402–11.
Ridker PM, Cushman CH, Buring JE, et al. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in woman. N Eng J Med. 2000;342:836–43.
Ridker PM, Rifai N, Stampfer MJ, et al. Plasma concentration of interleukin-6 and the risk of future myocardial infarction among apparently healthy men. Circulation. 2000;101:1767–72.
Harris TB, Ferrucci L, Tracy RP, et al. Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506–12.
Ridker PM, Rifai N, Pfeffer M, et al. Elevation of tumor necrosis factor-α and increased risk of recurrent coronary events after myocardial infarction. Circulation. 2000;101:2149–53.
Shoenfeld Y, Gerli R, Doria A, et al. Accelerated atherosclerosis in autoimmune rheumatic diseases. Circulation. 2005;112:3337–47.
Urowitz MB, Bookman AA, Koehler BE, et al. Am J Med. 1976;60:221–5.
del Rincon ID, Williams K, Stern MP, et al. High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 2001;44:2727–45.
Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation. 2003;107:1303–7.
Wolfe F, Michaud K. The risk of myocardial infarction and pharmacologic and nonpharmacologic myocardial infarction predictors in rheumatoid arthritis. Arthritis Rheum. 2008;58:2612–21.
Gabriel SE, Crowson CS, O’Fallon WM. Comorbidity in arthritis. J Rheumatol. 1999;26:2475–9.
del Rincon I, Freeman GL, Haas RW, et al. Relative contribution of cardiovascular risk factors and rheumatoid arthritis clinical manifestations to atherosclerosis. Arthritis Rheum. 2005;52:3413–23.
Urowitz MB, Ibanez D, Gladman DD. Athersclerotic vascular events in a single large lupus cohort: prevalence and risk factors. J Rheumatol. 2007;34:70–5.
Esdaile JM, Abrahamowicz M, Grodzicky T, et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum. 2001;44:2331–7.
Petri M, Perez-Gutthann S, Spence D, et al. Risk factors for coronary artery disease in patients with systemic lupus erythematosus. Am J Med. 1992;93:513–9.
Manoussakis MN, Georgopoulou C, Zintzaras E, et al. Sjogren’s syndrome associated with SLE: clinical and laboratory profiles and comparison with primary SS. Arthritis Rheum. 2004;50:882–91.
Mantilla CB, Horlocker TT, Schroeder DR. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002;96:1140–6.
Parviz J, Keshavarzi NR, et al. Revision total hip arthroplasty in octogenarians. A case control study. J Bone Joint Surg. 2007;89:2612–8.
Zhan C, Kaczmarek R, Layo-Berrios N, et al. Incidence and short-term outcome of primary and revision hip replacements in the United States. J Bone Joint Surg. 2007;89:526–33.
Urban MK, Jules-Elysee K, Loughlin C et al. The one-year incidence of postoperative myocardial infarction in an orthopedic population. HSS Jour 2008;4(1):76–80.
Pioli G, Barone A, Oliveri M, et al. Predictors of mortality after hip fracture: results from 1-year follow-up. Aging Clin Exp Res. 2006;5:381–7.
Lawrence VA, Hilslenbeck SG, Noveck H, et al. Medical complications and outcomes after hip fracture repair. Arch Intern Med. 2002;14(1620):2053–7.
Cloyd JM, Acosta FL, Ames CP. Complications and outcomes of lumbar spine surgery in elderly people: a review of the literature. JAGS. 2008;56:1318–27.
Lee TH, Marccantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. 1999;100:1043–9.
Devereaux PI, Yang H, Yusef S, et al. Effects of extended release metoprolol succinate in patients undergoing noncardiac surgery (POISE Trial): A randomized control trial. Lancet. 2008;371:1839–47.
Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. N Eng J Med. 1977;297:845–50.
Detsky AS, Abrams HB, McLaughlin JR, et al. Predicting cardiac complications in patients undergoing noncardiac surgery. J Gen Intern Med. 1986;1:211–9.
Boersma E, Kertai MD, Schouten O, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. Am J Med. 2005;118:1134–41.
Lawrence VA, Hilsenbeck SG, Noveck H, et al. Medical complications and outcomes after hip fracture repair. Arch Intern Med. 2002;14(162):2053–7.
Sinatra RS, Torres J, Bustos AM. Pain management after major orthopedic surgery: current strategies and new concepts. J Am Acad Orthop Surg. 2002;10:117–29.
Kertai MD, Boersma E, Bax BJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart. 2003;89:1327–34.
Etchells E, Meade M, Tomlinson G, et al. Semiquantitative dipyridamole myocardial stress perfusion imaging for cardiac risk assessment before noncardiac vascular surgery: a metaanalysis. J Vasc Surg. 2002;36:535–40.
Salerno Sm, Carlson DW, Soh EK, Lettieri CJ. Impact of perioperative cardiac assessment guidelines on management of orthopedic surgery patients. Am J Med. 2007;120:185e1–6.
Poldermans D, Bax JJ, Schoufen O, et al. Dutch echocardiographic cardiac risk evaluation applying stress echo study group. J Am Coll Cardiol. 2006;48:964–9.
Eagle KA, Rihai CS, Mickel MC, et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. Circulation. 1997;96:1882–7.
McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. N Eng J Med. 2004;351:2795–804.
Vicenzi MN, Meislitzer T, Heitzinger B, et al. Coronary artery stenting and noncardiac surgery –-a prospective outcome study. Br J Anaesth. 2006;96:686–93.
Biondi-Zoccai GC, Agostoni P, Abbate A, et al. Adjusted indirect comparison of intracoronary drug eluting sten: evidence for a metaanalysis of randomized bare metal stent controlled trials. Int J Cardiol. 2005;100:119–23.
Spahn Dr, Howell SJ, Delabays A, et al. Coronary stents and perioperative anti-platelet regimen: dilemma of bleeding and stent thrombosis. Br J Anaesth. 2006;96:675–7.
Fleisher LA, Beckman JA, Brown KA, et al. ACC/AJA 2007 guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (Writing Committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation 2007;116 (17):1971–1996.
Raby KE, Brull SJ, Yimimi F, et al. The effect of heart rate on myocardial ischemia among high-risk patients after vascular surgery. Anesth Anal. 1999;88:477–82.
Urban MK, Markowitz SM, Gordon MA, et al. Postoperative prophylactic administration of beta-adrenergic blockers in patients at risk for myocardial ischemia. Anesth Analg. 2000;90:1257–61.
Fleischer LA, Beckman JA, Brown KA, et al. ACC/AHA guideline update on perioperative cardiovascular evaluation for noncardiac surgery: focused update on perioperative beta-blocker therapy. Anesth Analg. 2007;104:15–26.
Devereaux PJ, Beattie WS, Chou PT, et al. How strong is the evidence for the use of perioperative beta blockers in noncardiac surgery? Systematic review and meta-analysis of randomized controlled trials. BMJ. 2005;331:313–21.
Weisbauer F, Schlager O, Domanovits H, et al. Perioperative B-blockers for preventing surgery related mortality and morbidity: a systematic review and meta-analysis. Anesth Analg. 2007;104:27–41.
Howell SJ, Sear JS, Foex P. Hypertension, hypertensive heart disease and perioperative risk. Br J Anaesth. 2004;92:570–83.
Abou-Chebl A, Yadav JS, Reginelli JP, et al. Intracranial hemorrhage and hyperperfusion syndrome following carotid surgery. Risk factors, prevention and treatment. J Am Coll Cardiol. 2004;43:1596–601.
Durazzo AD, Marchado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. J Vasc Surg. 2004;39:967–76.
Lindenauer PK, Pekow P, wang K, et al. Lipid-lowering therapy and in-hospital mortality following major noncardiac surgery. JAMA. 2004;291:2092–9.
Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. 2003;107:1848–51.
Schouten O, Boersma E, Hoeks SE. The Dutch echocardiographic cardiac risk evaluation applying stress echocardiography study group. Fluvastatin and perioperative events in patients undergoing vascular surgery. N Engl J Med. 2009;361:980–9.
Heeschen C, Hamm CW, Laufs U, et al. Withdrawal of statins increases event rates in patients with acute coronary syndromes. Circulation. 2002;105:1446–52.
Welten GMJM, Chonchol M, Schouten O, et al. Statin use is associated with early recovery of kidney injury after vascular surgery and improved long-term outcome. Nephrol Dial Transplant. 2008;23:3867–73.
Poldermans D. Statins and non-cardiac surgery: current evidence and practical considerations. Cleve Clin J Med. 2009;76:S79–83.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
MacKenzie, C.R., Urban, M.K. (2013). Preoperative Cardiovascular Risk Assessment. In: Mandell, B. (eds) Perioperative Management of Patients with Rheumatic Disease. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-2203-7_5
Download citation
DOI: https://doi.org/10.1007/978-1-4614-2203-7_5
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4614-2202-0
Online ISBN: 978-1-4614-2203-7
eBook Packages: MedicineMedicine (R0)